Guidance for Pharmacists on the Safe Supply of non-Prescription Ulipristal Acetate 30mg (ellaOne®) for Emergency Hormonal Contraception

The purpose of this guidance is to ensure pharmacists supply ellaOne® safely and appropriately to patients.

Guidance for Pharmacists on the Safe Supply of non-Prescription Ulipristal Acetate 30mg (ellaOne®) for Emergency Hormonal Contraception pdf cover

In this guidance we highlight key points that should be considered by pharmacists in ensuring the safe supply of ellaOne® to patients.

Due to the nature of this medicine and the associated patient counselling requirements, a private consultation between the pharmacist and the individual patient is required. This consultation should take place in the pharmacy’s patient consultation area.

The products Summary of Product Characteristic (SmPC) and Package Leaflet are available to view on the HPRA website.